(VIANEWS) – KAUFMAN ET BROAD (KOF.PA), BOIRON (BOI.PA), BOURSE DIRECT (BSD.PA) are the highest payout ratio stocks on this list.
Here’s the data we’ve collected of stocks with a high payout ratio at the moment. The payout ratio in itself isn’t a promise of a future good investment but it’s an indicator of whether dividends are being paid and how the company chooses to distribute them.
When investigating a potential investment, the dividend payout ratio is a good statistic to know so here is a list of some companies with an above 30% payout ratio.
1. KAUFMAN ET BROAD (KOF.PA)
110.6% Payout Ratio
Kaufman & Broad S.A. operates as a property developer and builder in France. It designs, develops, builds, and sells single-family homes in communities, managed residences, offices, shops, hotels, and logistics platforms and business parks. The company was founded in 1968 and is headquartered in Courbevoie, France.
Earnings Per Share
As for profitability, KAUFMAN ET BROAD has a trailing twelve months EPS of €3.1.
PE Ratio
KAUFMAN ET BROAD has a trailing twelve months price to earnings ratio of 8.71. Meaning, the purchaser of the share is investing €8.71 for every euro of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 25.33%.
More news about KAUFMAN ET BROAD.
2. BOIRON (BOI.PA)
53.4% Payout Ratio
Boiron SA manufactures and sells homeopathic medicines in France, rest of Europe, North America, and internationally. The company offers non-proprietary homeopathic medicines and homeopathic specialties; and other healthcare products include medical devices, invitro diagnostics, dietary supplements, cosmetics, and phytotherapy. It also provides homeopathic specialties comprising Oscillococcinum to treat influenza symptoms, such as fever, chills, headaches, and aches; Stodal and Stodaline for treating coughs; Arnigel for adjunctive local treatment of benign trauma in the absence of open wounds; Camilia for the treatment of teething problems for babies; Sédatif PC to treat anxiety and emotional, and minor sleep disorders; Coryzalia for the treatment of cold symptoms and rhinitis; Homéoptic to treat eye discomfort and irritation due to various causes for adults and children; Homéovox for vocal disorders; Homéoplasmine for treating irritated skin and redness; Varésol to treat symptoms of chickenpox; and Arnicare Arthritis for use in the treatment of benign trauma pain. In addition, it offers Dermoplasmine, a plant based multi-use balm that repairs and protects irritated and damaged skin; COVID self-tests and rapid antigenic tests; LABIAMEO, that used to treat outbreaks of localized cold sores; and CONVAMEO to treat physical and mental asthenia. The company offers its products through distribution centers, pharmacies, pharmacy chains, wholesalers, grocery and drugstores, health food stores, and online retail. Boiron SA was founded in 1932 and is headquartered in Messimy, France.
Earnings Per Share
As for profitability, BOIRON has a trailing twelve months EPS of €2.74.
PE Ratio
BOIRON has a trailing twelve months price to earnings ratio of 12.27. Meaning, the purchaser of the share is investing €12.27 for every euro of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 7.15%.
Volume
Today’s last reported volume for BOIRON is 1545 which is 88.44% below its average volume of 13371.
More news about BOIRON.
3. BOURSE DIRECT (BSD.PA)
47.45% Payout Ratio
Bourse Direct SA provides Internet stock brokerage services in France. It offers a platform of services, tools, and financial products, including French and foreign equities, derivatives, trackers, warrants, certificates, turbos, mutual funds, UCITS, and CFDs, as well as tax exemption, retirement, real estate, and life insurance products through the boursedirect.fr, capitol.fr, tradebox.fr, abssysteme.fr, wargny.com, and mesactions.com sites. The company was founded in 1996 and is headquartered in Paris, France. Bourse Direct SA is a subsidiary of E-VIEL SA. Bourse Direct et Bourse Discount SA provides French and foreign equities, derivatives, trackers, warrants, certificates, turbos, UCITS, CFDs, tax exemption products, real estate products, and direct horizon stock exchange life insurance contracts. The company was was incorporated in 1996 and is based in Paris, France.
Earnings Per Share
As for profitability, BOURSE DIRECT has a trailing twelve months EPS of €0.3.
PE Ratio
BOURSE DIRECT has a trailing twelve months price to earnings ratio of 17. Meaning, the purchaser of the share is investing €17 for every euro of annual earnings.
Moving Average
BOURSE DIRECT’s worth is below its 50-day moving average of €5.23 and below its 200-day moving average of €5.19.
Revenue Growth
Year-on-year quarterly revenue growth grew by 15.1%, now sitting on 71.24M for the twelve trailing months.
Dividend Yield
According to Morningstar, Inc., the next dividend payment is on May 22, 2024, the estimated forward annual dividend rate is 0.16 and the estimated forward annual dividend yield is 3.08%.
Volume
Today’s last reported volume for BOURSE DIRECT is 4375 which is 80.06% below its average volume of 21948.
More news about BOURSE DIRECT.
4. EIFFAGE (FGR.PA)
39.16% Payout Ratio
Eiffage SA engages in the construction, property development, urban development, civil engineering, metallic construction, roads, energy systems, and concessions businesses in France and internationally. The company operates through Construction, Infrastructure, Energy Systems, Concessions, and Holding Company segments. The Construction segment offers urban development, building design and construction, property development, and maintenance and facilities management services. The Infrastructure segment is involved in undertaking civil engineering, road and rail design and construction, drainage, earthworks, and metallic construction. The Energy Systems segment designs, constructs, integrates, operates, and maintains energy and telecommunication systems and equipment. The Concessions segment constructs and manages concession contracts and public-private partnerships. The company was founded in 1844 and is based in Vélizy-Villacoublay, France.
Earnings Per Share
As for profitability, EIFFAGE has a trailing twelve months EPS of €10.65.
PE Ratio
EIFFAGE has a trailing twelve months price to earnings ratio of 9.87. Meaning, the purchaser of the share is investing €9.87 for every euro of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 19.49%.
Volume
Today’s last reported volume for EIFFAGE is 49234 which is 73.61% below its average volume of 186578.
More news about EIFFAGE.
1. 1 (1)
1% Payout Ratio
1
Earnings Per Share
As for profitability, 1 has a trailing twelve months EPS of €1.
PE Ratio
1 has a trailing twelve months price to earnings ratio of 1. Meaning, the purchaser of the share is investing €1 for every euro of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 1%.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, 1’s stock is considered to be overbought (>=80).
Sales Growth
1’s sales growth is 1% for the current quarter and 1% for the next.
Growth Estimates Quarters
The company’s growth estimates for the present quarter and the next is 1% and 1%, respectively.
More news about 1.
